Publication Ethics

Ethical Publication in the Pharmaceutical Reports

Editorial Board

  • Honesty and Integrity

Authors are expected to present their research findings truthfully and accurately, without fabricating, falsifying, or manipulating data. They should also accurately cite the work of others and disclose any conflicts of interest.

PharmRep is dedicated to publishing original research studies and timely reviews that have not been previously published or are currently under review elsewhere. All the redundant publications, which are involved in an inappropriate dividing of study outcomes into several articles, will face the “Redundant Publication Sanctions”. Suspected redundant (duplicate) publication a submitted manuscript (PDF, 60 kb) and in a published article (PDF, 84 kb).

  • Originality and Plagiarism

Authors must ensure that their work is original and properly acknowledges the contributions of others. Plagiarism, the unauthorized use or appropriation of someone else's work, ideas, or words, is strictly prohibited.

Any plagiarized materials will be subject to "Plagiarism Sanctions". Manuscripts that are found to be published or under review elsewhere will be rejected and subject to "Duplicated Publication Sanctions". Manuscripts that contain fabricated or falsified data, including image manipulation, will be considered a breach of integrity and confronted with "Data Fabrication/Falsification Sanctions".

  • Suspected plagiarism in a submitted manuscript (PDF, 80 kb) and in a published article (PDF, 76 kb).
  • Suspect fabricated data in a submitted manuscript (PDF, 84 kb) and in a published article (PDF, 84 kb)
  • Authorship

Authorship should be based on substantial contributions to the research study and drafting of the manuscript. All listed authors should have made significant contributions and should agree to be accountable for the work.

All listed authors are required to have significant scientific contributions to the research of the submitted manuscript and also approved the claimed findings. According to the ICMJE, the authorship should be based on the following criteria:

  • Substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data.
  • Drafting the work or revising it critically for important intellectual content.
  • Final approval of the version published.
  • Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
  • Peer Review

Peer review is a critical process in scholarly publishing, where experts in the field evaluate the quality and validity of research manuscripts. Reviewers should provide constructive feedback and maintain confidentiality.

  • Conflicts of Interest

Authors, reviewers, and editors should disclose any conflicts of interest that could potentially bias their judgment or influence the interpretation of research findings.

  • If a reviewer suspects undisclosed conflict of interest in a submitted manuscript (PDF, 56 kb)
  • If a reader suspects undisclosed conflict of interest in a published article (PDF, 56 kb)
  • Transparency and Reproducibility

Authors should provide sufficient detail and data to enable others to replicate their research findings. Raw data and materials should be made available upon request.

  • Ethical Treatment of Subjects

Research involving human subjects or animals must adhere to ethical standards and obtain appropriate approvals from institutional review boards or ethics committees. Please click to read the Ethical Principles for Medical Research Involving Human Subjects.

  • Editorial Independence

Editors should make decisions based on the quality and validity of the research and should not be influenced by factors such as the author's reputation, institutional affiliation, or financial interests.

  • Corrections and Retractions

If errors are discovered in published work, authors and editors should promptly issue corrections or retractions to ensure the accuracy and integrity of the scientific record.

Based on the COPE guidelines on the retraction, PharmRep will consider retracting a publication if:

  • It has clear evidence that the findings are unreliable, either as a result of misconduct (e.g. data fabrication) or honest error (e.g. miscalculation or experimental error).
  • The findings have previously been published elsewhere without proper crossreferencing, permission, or justification (i.e. cases of redundant publication).
  • It constitutes plagiarism.
  • It reports unethical research.
  • Request for addition of extra author before (PDF, 52 kb) or after publication (PDF, 68 kb)
  • Request for removal of the author before publication (PDF, 52 kb)
  • Request for removal of author Suspected guest or gift authorship (PDF, 76 kb)
  • Advice on how to spot authorship problems (PDF, 64 kb)
  • Responsible Conduct

All parties involved in scholarly publishing should adhere to high ethical standards and promote responsible conduct in research and publication.

  • Other Considerations
  • If we suspect an ethical problem with a submitted manuscript (PDF, 68 kb)
  • If we suspect a reviewer has appropriated an author’s idea or data (PDF, 88 kb)
  • How COPE handles complaints against editors (PDF, 68 kb)

Adherence to publication ethics is essential for maintaining the credibility and trustworthiness of the scientific literature, fostering collaboration and innovation, and ultimately advancing knowledge in all fields of study.

 

 

Makassar, January 1st 2022

Muammar Fawwaz, Ph.D.

Editor in Chief Pharmaceutical Reports

Makassar-Indonesia, 90231

muammar.fawwaz@umi.ac.id

pharmaceutical.reports@umi.ac.id

This is an open access article which is publicly available on our journal’s website under Institutional Repository at https://www.umi.ac.id/id/